Abiopharma

🔍 BOTHA ROELOF (Director)

Company: Unity Software Inc. (U)

Report Date: 2026-05-13

Detailed Transactions and Holdings:

• Acquired 13,201 shares of Common Stock (Direct)
  Date: 2026-05-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 26,407.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-13 | Code: H | nature_of_ownership: By estate planning vehicle | shares_owned_after: 621,902.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-13 | Code: H | nature_of_ownership: Sequoia Capital Fund Parallel, LLC | shares_owned_after: 3,173,556.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-13 | Code: H | nature_of_ownership: Sequoia Capital Fund, LP | shares_owned_after: 28,651,368.00 | Footnotes: F2

Footnotes:

• F1: Represents restricted stock units granted to the Reporting Person. The shares subject to this award vest in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service through such date.
• F2: The Reporting Person is a director and stockholder of SC US (TTGP), Ltd. SC US (TTGP), Ltd. is (i) the general partner of Sequoia Capital Fund Management, L.P., which is the general partner of Sequoia Capital Fund, LP (SCF) and the managing member of Sequoia Capital Fund Parallel, LLC (SCFP). As a result, the Reporting Person may be deemed to share voting and dispositive power with respect to the shares held by SCF and SCFP. The Reporting Person disclaims beneficial ownership of the securities included in the report except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.